Company Filing History:
Years Active: 2008-2013
Title: The Innovations of Olle Larsson
Introduction
Olle Larsson is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of medical research, particularly in the development of compounds that target the insulin-like growth factor-1 receptor. With a total of five patents to his name, Larsson's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Olle Larsson's latest patents is focused on the use of specific cyclolignans. This invention refers to compounds wherein the carbon atoms in positions 9 and 9' have a cis configuration, which can inhibit the insulin-like growth factor-1 receptor. These compounds are particularly useful for treating IGF-1R dependent diseases, such as cancer, psoriasis, atherosclerosis, and acromegaly. A preferred compound identified in this patent is picropodophyllin. Another patent involves the use of cyclolignans and new cyclolignans, which also inhibit the insulin-like growth factor-1 receptor and provide methods for treating related diseases.
Career Highlights
Throughout his career, Olle Larsson has worked with various companies, including Axelar AB and Biovitrum AB. His innovative research has positioned him as a key figure in the development of therapeutic solutions targeting critical health issues.
Collaborations
Olle Larsson has collaborated with several professionals in his field, including his coworker Magnus Axelson. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Olle Larsson's contributions to the field of medical research through his innovative patents highlight his role as a significant inventor. His work on cyclolignans and their applications in treating serious diseases showcases the potential for advancements in medical therapies.